Company Description
Blackrock Health Sciences Trust (BME) is a closed-end investment fund focused on the finance and insurance sector, within the securities and commodity exchanges industry. According to its stated investment objective, the trust seeks to provide total return through a combination of current income, current gains, and long-term capital appreciation. It does this by investing primarily in equity securities of companies engaged in health sciences and related industries, as well as in equity derivatives.
The trust’s strategy, as described in available information, is to invest at least 80% of its total assets in equity securities of health sciences companies and related industries and in equity derivatives. This focus on health sciences means the portfolio is concentrated in businesses connected to healthcare and related fields, while the use of equity derivatives is intended to support the objective of generating current income, gains, and capital appreciation over time.
Investment Objective and Strategy
The core objective of Blackrock Health Sciences Trust is to generate a total return that combines:
- Current income
- Current gains
- Long-term capital appreciation
To pursue this objective, the fund states that it invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and in equity derivatives. This approach aligns the trust with the performance and developments of the health sciences space, while also allowing it to use derivatives linked to equity markets as part of its strategy.
Sector and Industry Classification
For classification purposes on Stock Titan, Blackrock Health Sciences Trust is associated with the Finance and Insurance sector and the Securities and Commodity Exchanges industry. This reflects its structure as an investment vehicle whose shares trade in public markets and whose primary activity is investing in securities rather than producing or selling health-related products or services directly.
Health Sciences Focus
The trust’s emphasis on companies engaged in health sciences and related industries means its portfolio is tied to businesses operating in or around the broader healthcare ecosystem. While specific holdings are not detailed in the provided information, the mandate clearly links the fund’s investments to equity securities in that area and to equity derivatives connected to those markets.
Use of Equity Derivatives
Available information notes that Blackrock Health Sciences Trust invests in equity derivatives alongside equity securities. These instruments are used as part of the trust’s effort to achieve its stated objectives of current income, current gains, and long-term capital appreciation. The exact types of derivatives or strategies are not specified in the provided data, but their inclusion is a defined part of the investment approach.
Relationship to BlackRock
The trust carries the Blackrock name, indicating association with the broader BlackRock fund family. Separate news items describe BlackRock, Inc. as a fiduciary to investors and a provider of financial technology that helps people build savings by making investing easier and more affordable. However, the news materials focus on BlackRock at the corporate level and on other products and platforms, not on BME specifically, so they are best understood as general context about the sponsor brand rather than detailed information about this particular trust.
Trading and Investor Considerations
As an investment fund classified in the securities and commodity exchanges industry, Blackrock Health Sciences Trust is designed for investors who want exposure to health sciences and related industries through a professionally managed, exchange-traded vehicle. The fund’s objective and 80% investment policy are central reference points for understanding how it is intended to operate. Specific details such as current portfolio composition, distribution policy, or leverage, if any, are not provided in the available data and would need to be obtained from official fund documents.
Evergreen Characteristics
The elements that define Blackrock Health Sciences Trust in a durable way are its:
- Stated objective of total return through current income, current gains, and long-term capital appreciation
- Policy to invest 80% of total assets in equity securities of health sciences and related industries and in equity derivatives
- Placement in the finance and insurance sector and securities and commodity exchanges industry
These characteristics describe the structural design of the trust rather than short-term performance or time-sensitive details, making them useful for long-term reference when researching the BME stock.
Stock Performance
BlackRock Health Sciences (BME) stock last traded at $38.67, up 1.27% from the previous close. Over the past 12 months, the stock has lost 0.8%, ranking #1,123 in 52-week price change. At a market capitalization of $505.3M, BME is classified as a small-cap stock with approximately 13.3M shares outstanding.
Latest News
BlackRock Health Sciences has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include earnings, AI, conferences. View all BME news →
SEC Filings
BlackRock Health Sciences has filed 4 recent SEC filings, including 2 Form 4, 1 Form N-CEN, 1 Form N-CSR. The most recent filing was submitted on March 13, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BME SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in BlackRock Health Sciences (BME) currently stands at 59.0 thousand shares, down 3.3% from the previous reporting period, representing 0.4% of the float. Over the past 12 months, short interest has increased by 1101.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for BlackRock Health Sciences (BME) currently stands at 1.5 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 53% over the past year, indicating either rising short interest or declining trading volume.
BME Company Profile & Sector Positioning
BlackRock Health Sciences (BME) operates in the Asset Management industry within the broader Financial Services sector and is listed on the NYSE. Among dividend-paying stocks, BME ranks #273 by dividend yield. In monthly performance, the stock ranks #1,243 among all tracked companies.
Investors comparing BME often look at related companies in the same sector, including abrdn World Healthcare (THW), Gabelli Utility Trust (GUT), BlackRock Enhanced Intl Div Trust (BGY), Pennantpark Invt Corp (PNNT), and Duff & Phelps Utility and Infra Fund Inc (DPG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BME's relative position within its industry.